Jade Biosciences annual r&d spending
2020
2021
2022
2023
2024
2025
Jade Biosciences R&D Spending Growth & History (JBIO)
Jade Biosciences's r&d spending was $93.1M for fiscal 2025.
View full Jade Biosciences company overviewJade Biosciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $93.1M | $39.9M | +75.08% |
| 2024 | 2024-12-31 | $53.2M | −$11.0M | −17.18% |
| 2023 | 2023-12-31 | $64.2M | $25.6M | +66.28% |
| 2022 | 2022-12-31 | $38.6M | $23.6M | +157.70% |
| 2021 | 2021-12-31 | $15.0M | $7.0M | +88.75% |
| 2020 | 2020-12-31 | $7.9M | — | — |
Jade Biosciences quarterly r&d spending
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $50.1M | $27.5M | +122.05% |
| Q1 2026 | 2026-03-31 | $36.1M | $16.0M | +80.06% |
| Q4 2025 | 2025-12-31 | $28.5M | — | — |
| Q3 2025 | 2025-09-30 | $22.0M | $8.4M | +62.06% |
| Q2 2025 | 2025-06-30 | $22.5M | $1.3M | +6.11% |
| Q1 2025 | 2025-03-31 | $20.0M | −$57,000 | −0.28% |
| Q3 2024 | 2024-09-30 | $13.6M | −$3.3M | −19.56% |
| Q2 2024 | 2024-06-30 | $21.2M | $5.2M | +32.52% |
| Q1 2024 | 2024-03-31 | $20.1M | $6.6M | +48.87% |
| Q4 2023 | 2023-12-31 | $17.8M | $5.6M | +45.76% |
| Q3 2023 | 2023-09-30 | $16.9M | $6.1M | +56.58% |
| Q2 2023 | 2023-06-30 | $16.0M | $7.7M | +91.73% |
| Q1 2023 | 2023-03-31 | $13.5M | $6.2M | +85.91% |
| Q4 2022 | 2022-12-31 | $12.2M | $7.2M | +142.19% |
| Q3 2022 | 2022-09-30 | $10.8M | $7.4M | +215.48% |
| Q2 2022 | 2022-06-30 | $8.4M | $4.0M | +93.27% |
| Q1 2022 | 2022-03-31 | $7.3M | $5.1M | +230.37% |
| Q4 2021 | 2021-12-31 | $5.0M | — | — |
| Q3 2021 | 2021-09-30 | $3.4M | $1.5M | +73.86% |
| Q2 2021 | 2021-06-30 | $4.3M | $2.9M | +194.15% |
| Q1 2021 | 2021-03-31 | $2.2M | — | — |
| Q3 2020 | 2020-09-30 | $2.0M | — | — |
| Q2 2020 | 2020-06-30 | $1.5M | — | — |
Jade Biosciences r&d spending trends
Over the last five fiscal years, Jade Biosciences's r&d spending increased from $7.9M to $93.1M, a change of $85.2M. The latest reported quarter, Q2 2026, shows $50.1M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jade Biosciences source filings ↗